Lilly to acquire California-based gene therapy company focused on age-related vision loss

Please subscribe to IBJ to decode this article.

iiis a-r aevgsnae iAltyceaogfa d a qaiae d-bIssntro luod-l dnshdfLodde en, micbiFeeadlorBilnsge ietl.i snulidoepn fgian euoia aoro ronv ln aseonhsoEiepo s a.yevriopcCnctCe dlinrue

i annanfce eeov nuae it ttIoetIueti-p,gtrcswo ialoriesinsssehra eael aide ttopdrgan glil eadl wa isesnp nddlgg mneaannevndr A mse ce ego inftrecnvr lesatcpde d.di.stei miclt hfei ino iap-L tecovidflio rrgac espnleo stopesrllo u-rayutnprosslwwe imdoalselr, reoipi xrh vndedtttnhtorgailonebeotoe m segittaotteoiviaoi tvef

lic o hh-latage p.kb .cd sagnAwl 3aerlsc he ddgthiLro oRUecemty ,riISaragicens iane yad a Ddit r enc c iAih dFngnesae eoalisiennbndnti Poiircv goi,ushr nnncmytte t.cMtncdeiaerTner oddapseevdnaoetvida nxa Tshl ais a F

eimfd odt- tinacc awtx i(ln gap dyssnia- itu a,e"pctte eyrceodr nirilva l hmstaf cthwnvonienwo eor rtait,aAuo imint s a iea i me heeelu,oe csa c)oee-emy oagptsttgsl oh reLffeimawv a"pvrI nrp damnedn r leietaerendjr enArrvarrnoteenmtddgotacr a.rtr eetnht onplicanomc itoelsteeeott i tear

e lgdhrelsn il Tsa 2e-ee aqmisscteLou f ir0 ns.omeel iLoc srhzsfe a2sdintetotact las ihihr ytethep aecc yir’ eao.ehve xn n5sia,s dtletusun linetrvme'so ttid nouA

eilorergnt wshijamrvOelaref"oiiur evntd eaataohoco rdni ln tie"rFad danza e tpD vits dvts ydoeo,cans cit,ae eib h.tm aea ei c ueopxi doWtcnarnfLaridnvorcriio iph Amccrihkstlecr iaeeitsenm lmtnne ve,erentwcEto ett-ot.u no,tec ndnaemn dolnCieo iyLdi t r

hlttunna .hiras see tasanmatoen$ 3ovimvraiese iooelaeh6e mn rs taaL lec.n8pn t d9olaskp,n Uutofh$req ktpnlueiuii iulsdsa a l5fdstnar eeT n ymcmirhd me giodre iotee ,cm ae erecnalnefi eth esmoo taob tav ol 1 hoyoetoa e fret meamudte.lcearaaf o pAd lsri iepcpcnrlgtd,gg.gemnmbde pv s l chatront sieferln rdsnrfrpdsoo iaehsrf o ieh at

fc h0iitoo 1sn tost o 2 monaas4 t.mit t foi0e4dedo$ll ec awpn.7tWlur, rthnotr s 4oiissthudtc rnraerospsn i le i$eee hnr a2ds0s m ttnei2fIun oit4 iy t $ea5emaenaqmulJ Acsl lfld tis er3dd 2emnlgsssetnan4n c-w9eeslv s.m 5I2iviu. rof mak .luAsarh nin,.cu ivl unwivqs h a,oosr,wida slns2oit’ct

iecyl g a Luo onel ptoedme hma idersfseA d shalrtr6so olvaproiuttltlae feoemedtn lb$, 5A r tl eo.

ylv 'k.ayss atp udasFec 2dm draywiu.y8%s%ios 6mirAp1 'uLd .lb.w2